GLUT1 deficiency

GLUT1 deficiency syndrome (GLUT1-DS) is a rare genetic disorder that impairs brain metabolism. It is caused by mutations in the SLC2A1 gene, which encodes the glucose transporter protein GLUT1. This protein facilitates the transport of glucose across the blood-brain barrier, a critical process for providing energy to the central nervous system. The deficiency in GLUT1 results in inadequate glucose available to the brain, leading to a variety of neurological symptoms.

Symptoms and Signs[edit | edit source]

The clinical presentation of GLUT1 deficiency syndrome can vary widely among affected individuals. Common symptoms include:

Epilepsy: Seizures of various types that are often resistant to standard antiepileptic drugs.
Developmental delay and intellectual disability: Varying degrees of cognitive impairment.
Movement disorders: Including ataxia (lack of muscle coordination), dystonia (involuntary muscle contractions), and spasticity.
Microcephaly: A condition where the head circumference is smaller than normal for an individual's age and sex.

Diagnosis[edit | edit source]

Diagnosis of GLUT1 deficiency syndrome involves a combination of clinical evaluation, laboratory testing, and genetic testing. Key diagnostic tests include:

Lumbar puncture to measure glucose levels in the cerebrospinal fluid (CSF). A low CSF glucose level (hypoglycorrhachia) with a normal blood glucose level is indicative of GLUT1 deficiency.
Genetic testing to identify mutations in the SLC2A1 gene.

Treatment[edit | edit source]

There is no cure for GLUT1 deficiency syndrome, but the condition can be managed with dietary therapy. The ketogenic diet, which is high in fats and low in carbohydrates, is the primary treatment. This diet provides an alternative source of energy for the brain, bypassing the need for glucose transport.

Prognosis[edit | edit source]

The prognosis for individuals with GLUT1 deficiency syndrome varies. Early diagnosis and management with the ketogenic diet can improve symptoms and quality of life. However, some individuals may continue to experience neurological symptoms and developmental delays.

Epidemiology[edit | edit source]

GLUT1 deficiency syndrome is a rare condition, with an estimated incidence of 1 in 90,000 births. It affects males and females equally.

History[edit | edit source]

GLUT1 deficiency syndrome was first described in 1991 by Dr. Darryl De Vivo and colleagues at Columbia University. Since then, over 300 cases have been reported worldwide.